Dr Reddy's Laboratories has assured to strengthen the commercial roll-out of Sputnik V vaccines in the coming weeks. "We will strengthen the commercial roll-out of Sputnik V in the coming weeks. Neither the ongoing soft commercial launch nor work towards its ramp-up in India has been put on hold," Dr Reddy's Laboratories said in a statement, posted in its Twitter handle on Monday.
The Sputnik V vaccine was launched on a soft pilot basis in India earlier on May 14. The nationwide soft launch of Sputnik V has reached over 50 cities and towns across the nation, Reports Hindustan Times.
Also read: Serum gets govt nod to produce Sputnik vaccine in India
Starting initially in Hyderabad, the soft launch roll-out of Sputnik V has scaled up speedily and reached cities and towns all over India - including but not limited to Hyderabad, Vizag, Bengaluru, Mumbai, Navi Mumbai, Kolkata, Delhi, NCR, Chennai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Kochi, Raipur, Chandigarh, Pune, Nagpur, Nashik, Coimbatore, Ranchi, Jaipur, Lucknow, Patna, Bhubaneshwar, Guwahati, Thiruvananthapuram, Ahmedabad, Rajkot, Palakkad, Allahabad, Dimapur, Kohima, Indore, Bhopal, Surat, Cuttack, Dharwad, Ernakulum, Ratlam, Faridabad, Srinagar, Gandhinagar, Vadodara, Gulbarga, Madurai, Guntur, Kannur, Jabalpur, Jalandhar, Kanpur, Mysore," said Dr Reddy's Laboratories statement.
Also read: Sputnik V production starts in India; 100 million doses to be produced annually
Dr Reddy's has partnered with major hospitals across the nation for this purpose, all of whom have successfully administered Sputnik V in India, including ongoing commercial roll-outs to the public.